Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions

Oxygen

Claudia C. Dobler
Breathe 2019 15: 161-162; DOI: 10.1183/20734735.0264-2019
Claudia C. Dobler
1Institute for Evidence-Based Healthcare, Bond University, Robina, Australia
2Dept of Respiratory Medicine, Liverpool Hospital, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Claudia C. Dobler
  • For correspondence: cdobler@bond.edu.au
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

The September issue of Breathe focuses on medical oxygen http://bit.ly/2M83NLo

Oxygen is on the World Health Organization's List of Essential Medicines, which includes the most efficacious, safe and cost-effective medicines for priority conditions. It is one of the most commonly used treatments in hospitalised patients, yet the evidence on its optimal use to improve clinical outcomes and reduce possible harm is relatively sparse. Oxygen should be prescribed like any other medication, for a specific indication, with a specific dose and with monitoring of the therapeutic response, but prescribing practices are often poor, increasing the risk of an adverse outcome.

In this issue we have a number of contributions on the topic of medical oxygen. One Journal Club article summarises and discusses the EOLIA trial, which aimed to assess whether patients with severe acute respiratory distress syndrome benefit from early initiation of venovenous extracorporeal membrane oxygenation (ECMO) [1]. The study showed no significant difference in mortality at 60 days in patients on ECMO compared with patients on conventional mechanical ventilation. However, a relatively high rate of 28% of patients in the control group crossing over to ECMO may have skewed the results in the intention-to-treat analysis. A second Journal Club article reports a multicentre trial that examined whether high-flow oxygen reduces escalation of care in infants with hypoxaemic bronchiolitis [2]. Treatment failure leading to escalation of care was reduced in the group that received high-flow oxygen therapy compared with the group that received standard oxygen therapy. The Lung Function Corner article describes the physiological responses in a patient with COPD breathing heliox or oxygen during exercise [3]. The authors conclude that heliox and oxygen administrated during rehabilitative exercise might result in greater functional and clinical benefits compared with exercise conducted while breathing room air if an increased training intensity is achieved, but not if the training intensity remains unchanged. The European Lung Foundation and the European Industrial Gases Association AISBL collaborated on an article that provides practical tips on air travel for people requiring oxygen therapy [4]. Furthermore, we hear from a patient about what it means to live with medical oxygen and how life can still be lived to the fullest despite disease- and treatment-related limitations [5]. Additional articles on oxygen will be made available as online exclusives on the Breathe website (https://breathe.ersjournals.com).

Other highlights in the September issue are an article on hot topics and current controversies in community-acquired pneumonia (CAP) [6] and a review of diagnostic imaging results in non-cystic fibrosis bronchiectasis [7]. The article on CAP examines the role of biomarkers to guide diagnosis and treatment of CAP, optimal antibiotic choice, the role of corticosteroids, association of CAP with subsequent cardiovascular risk, and the concept of healthcare-associated pneumonia [6]. The bronchiectasis article provides a concise overview of computed tomography findings in non-cystic fibrosis bronchiectasis in adults [7].

I would like to thank all the contributors to this issue who have given their time and shared their expertise, as well as the editorial team.

I look forward to seeing you at the ERS International Congress in Madrid!

Footnotes

  • Conflict of interest: C.C. Dobler has nothing to disclose.

  • Copyright ©ERS 2019
http://creativecommons.org/licenses/by-nc/4.0/

Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

References

  1. ↵
    1. Sameed M,
    2. Meng Z,
    3. Marciniak ET
    . EOLIA trial: the future of extracorporeal membrane oxygenation in acute respiratory distress syndrome therapy? Breathe 2019; 15: 244–246.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Mozun R,
    2. Pedersen ESL,
    3. Ardura-Garcia C
    . Does high-flow oxygen reduce escalation of care in infants with hypoxaemic bronchiolitis? Breathe 2019; 15: 247–249.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Louvaris Z,
    2. Vogiatzis I
    . Contrasting the physiological effects of heliox and oxygen during exercise in a patient with advanced COPD. Breathe 2019; 15: 250–257.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Orritt R,
    2. Powell P,
    3. Saraiva I
    . Why is medical oxygen a challenge for people travelling by air? Breathe 2019; 15: 182–189.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Mogensen K
    . Thoughts on medical oxygen, COPD and enjoying life. Breathe 2019; 15: 171–172.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Severiche-Bueno D,
    2. Parra-Tanoux D,
    3. Reyes LF, et al.
    Hot topics and current controversies in community-acquired pneumonia. Breathe 2019; 15: 216–225.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Juliusson G,
    2. Gudmundsson G
    . Diagnostic imaging in adult non-cystic fibrosis bronchiectasis. Breathe 2019; 15: 190–197.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Vol 15 Issue 3 Table of Contents
Breathe: 15 (3)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Oxygen
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Oxygen
Claudia C. Dobler
Breathe Sep 2019, 15 (3) 161-162; DOI: 10.1183/20734735.0264-2019

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Oxygen
Claudia C. Dobler
Breathe Sep 2019, 15 (3) 161-162; DOI: 10.1183/20734735.0264-2019
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Footnotes
    • References
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Pulmonary vascular disease for the general respiratory clinician
  • Sleep medicine in Europe: 50 years of evolution
  • Managing respiratory disease in pregnancy
Show more Editorials

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About Breathe

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Intructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 1810-6838
Online ISSN: 2073-4735

Copyright © 2023 by the European Respiratory Society